HK1203823A1 - Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv - Google Patents

Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv

Info

Publication number
HK1203823A1
HK1203823A1 HK15104317.1A HK15104317A HK1203823A1 HK 1203823 A1 HK1203823 A1 HK 1203823A1 HK 15104317 A HK15104317 A HK 15104317A HK 1203823 A1 HK1203823 A1 HK 1203823A1
Authority
HK
Hong Kong
Prior art keywords
treating diabetes
glycosylated apolipoprotein
apolipoprotein
glycosylated
diabetes
Prior art date
Application number
HK15104317.1A
Other languages
English (en)
Chinese (zh)
Inventor
Patrick Tso
Fei Wang
Sean Davidson
Original Assignee
Univ Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/021802 external-priority patent/WO2012100010A1/fr
Application filed by Univ Cincinnati filed Critical Univ Cincinnati
Publication of HK1203823A1 publication Critical patent/HK1203823A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK15104317.1A 2012-01-19 2015-05-06 Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv HK1203823A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2012/021802 WO2012100010A1 (fr) 2011-01-19 2012-01-19 Apolipoprotéine aiv utilisée en tant que peptide antidiabétique
US201261675692P 2012-07-25 2012-07-25
PCT/US2012/066314 WO2013109342A1 (fr) 2012-01-19 2012-11-21 Procédé de traitement du diabète à l'aide d'apolipoprotéine a-iv non glycosylée

Publications (1)

Publication Number Publication Date
HK1203823A1 true HK1203823A1 (en) 2015-11-06

Family

ID=48799573

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104317.1A HK1203823A1 (en) 2012-01-19 2015-05-06 Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv

Country Status (13)

Country Link
US (1) US9951120B2 (fr)
EP (1) EP2804618B1 (fr)
JP (1) JP6310398B2 (fr)
KR (1) KR20140117565A (fr)
CN (1) CN104066436B (fr)
AU (1) AU2012366182B2 (fr)
BR (1) BR112014017141A2 (fr)
CA (1) CA2860782A1 (fr)
EA (1) EA028230B1 (fr)
HK (1) HK1203823A1 (fr)
IL (1) IL233351A (fr)
MX (1) MX357071B (fr)
WO (1) WO2013109342A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX342020B (es) 2011-01-19 2016-09-08 Univ Cincinnati Apolipoproteina a-iv como un peptido antidiabetico.
MX357071B (es) 2012-01-19 2018-06-22 Univ Cincinnati Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes.
AU2012385960B2 (en) 2012-07-25 2017-04-13 University Of Cincinnati Method of treating hyperglycemic disorders using apolipoprotein AIV
WO2014018763A2 (fr) * 2012-07-25 2014-01-30 University Of Cincinnati Procédé de traitement du diabète de type i à l'aide de l'apolipoprotéine aiv
WO2015199041A1 (fr) * 2014-06-23 2015-12-30 東亞合成株式会社 Nouveau peptide synthétique et utilisation associée
CN112546201A (zh) * 2019-09-26 2021-03-26 中国科学院生物物理研究所 人工脂蛋白颗粒apoA-Ⅳ脂肪体在治疗和/或预防糖尿病中的应用
CN112891561A (zh) * 2021-03-09 2021-06-04 百码科技(深圳)有限公司 一种基因治疗脂肪肝的生物药剂及其制备方法
CN113018459A (zh) * 2021-03-09 2021-06-25 百码科技(深圳)有限公司 一种基因治疗减肥的生物药剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0402226A1 (fr) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Vecteurs de transformation de la levure yarrowia
FR2686605B1 (fr) * 1992-01-27 1994-03-11 Rhone Poulenc Rorer Sa Nouveaux polypeptides, leur preparation et leur utilisation.
WO1994027629A1 (fr) 1993-05-28 1994-12-08 Merck & Co., Inc. Procede de maitrise de l'appetit et de traitement de l'obesite
US6729075B2 (en) * 2000-10-19 2004-05-04 Wenger Corporation Audience seating system
CA2485989A1 (fr) 2002-05-17 2003-11-27 Esperion Therapeutics, Inc. Methodes et compositions permettant de traiter une reperfusion ischemique
US20080015265A1 (en) * 2006-07-11 2008-01-17 Byron Rubin Methods of treating obesity using satiety factors
US20100267052A1 (en) 2006-09-01 2010-10-21 American Type Culture Collection Compositions and methods for diagnosis and treatment of type 2 diabetes
AU2009226246A1 (en) * 2008-03-21 2009-09-24 Podiceps B.V. Diagnostic of pre-symptomatic metabolic syndrome
CN103788043B (zh) 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途
CN103068967B (zh) * 2010-08-30 2016-05-04 霍夫曼-拉罗奇有限公司 碱性进料
MX342020B (es) 2011-01-19 2016-09-08 Univ Cincinnati Apolipoproteina a-iv como un peptido antidiabetico.
MX357071B (es) 2012-01-19 2018-06-22 Univ Cincinnati Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes.
AU2012385960B2 (en) * 2012-07-25 2017-04-13 University Of Cincinnati Method of treating hyperglycemic disorders using apolipoprotein AIV
WO2014018763A2 (fr) 2012-07-25 2014-01-30 University Of Cincinnati Procédé de traitement du diabète de type i à l'aide de l'apolipoprotéine aiv

Also Published As

Publication number Publication date
AU2012366182B2 (en) 2017-08-17
IL233351A0 (en) 2014-08-31
BR112014017141A2 (pt) 2019-09-24
AU2012366182A8 (en) 2015-06-18
EP2804618B1 (fr) 2018-03-07
EA201491369A1 (ru) 2015-03-31
AU2012366182A1 (en) 2014-08-07
CN104066436A (zh) 2014-09-24
WO2013109342A1 (fr) 2013-07-25
KR20140117565A (ko) 2014-10-07
MX2014008829A (es) 2014-10-24
JP2015506942A (ja) 2015-03-05
IL233351A (en) 2016-12-29
CN104066436B (zh) 2016-12-14
EP2804618A1 (fr) 2014-11-26
US9951120B2 (en) 2018-04-24
MX357071B (es) 2018-06-22
US20150011469A1 (en) 2015-01-08
WO2013109342A8 (fr) 2014-09-04
CA2860782A1 (fr) 2013-07-25
JP6310398B2 (ja) 2018-04-11
EA028230B1 (ru) 2017-10-31

Similar Documents

Publication Publication Date Title
EP2675459A4 (fr) Composés et méthodes de traitement du diabète
EP2773754A4 (fr) Méthode de traitement
GB201110095D0 (en) Method of treatment
HK1203823A1 (en) Method of treating diabetes using non-glycosylated apolipoprotein a- iv a-iv
EP2774966A4 (fr) Procédé de traitement de surface du phosphore
EP2890391A4 (fr) Méthode et composition pour traiter l'hyperglycémie
PL2768785T3 (pl) Sposób obróbki termicznej warstw srebra
HK1201439A1 (en) Method of treating or reducing efp efp
HK1259004A1 (zh) 治療糖尿病的組合物和方法
HK1203370A1 (en) Method for treatment of labor arrest
ZA201403739B (en) Methods of treatment with deferiprone
HK1214355A1 (zh) 用於治療和/或限制糖尿病發展的方法
EP2816126A4 (fr) Procédé de traitement thermique
GB201108797D0 (en) Surface treatment method
IL228744A0 (en) A method for treating diseases related to interferon alpha
EP2709466A4 (fr) Méthode de traitement du miel
ZA201407215B (en) Method for emulsion treatment
HK1202819A1 (en) Treatment of type i and type ii diabetes i ii
GB201105523D0 (en) Treatment method
IL238331A0 (en) A method for treating type I and type II diabetes
EP2791324A4 (fr) Procédé de traitement
AP2014007425A0 (en) Treatment of sulphidic materials
EP2768536A4 (fr) Méthode de traitement des diabètes de type i et de type ii
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment